Drug
Regn1500
Regn1500: highest development phase Phase 1, developed by Regeneron. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- Regeneron
Trials
| Drug | Phase | Indication |
|---|---|---|
| REGN1500 NCT01749878 | Phase 1 | Hypertriglyceridemia |
Latest
No recent events.
Follow Regn1500 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.